Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival. | J Oncol | 2022 | 35222640 | PubTator, text mining | PubMed |
| Vav Proteins in Development of the Brain: A Potential Relationship to the Pathogenesis of Congenital Zika Syndrome? | Viruses | 2022 | 35215978 | PubTator, text mining | PubMed |
| The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation. | Sci Adv | 2022 | 35213231 | PubTator, text mining | PubMed |
| Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma. | Front Oncol | 2022 | 35211406 | PubTator, text mining | PubMed |
| Rad52 mediates class-switch DNA recombination to IgD. | Nat Commun | 2022 | 35190531 | PubTator, text mining | PubMed |
| A new era: tumor microenvironment in chemoresistance of pancreatic cancer. | J Cancer Sci Clin Ther | 2022 | 35187493 | PubTator, text mining | PubMed |
| Comprehensive analysis of immunocyte infiltration and the key genes associated with intraplaque hemorrhage in carotid atherosclerotic plaques. | Int Immunopharmacol | 2022 | 35183915 | PubTator, text mining | PubMed |
| Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition. | Front Oncol | 2022 | 35174079 | PubTator, text mining | PubMed |
| The Prominent Role of Hematopoietic Peptidyl Arginine Deiminase 4 in Arthritis: Collagen- and Granulocyte Colony-Stimulating Factor-Induced Arthritis Model in C57BL/6 Mice. | Arthritis Rheumatol | 2022 | 35166055 | PubTator, text mining | PubMed |
| Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2022 | 35163421 | PubTator, text mining | PubMed |
| KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders. | Cancers (Basel) | 2022 | 35158933 | PubTator, text mining | PubMed |
| HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease. | Front Immunol | 2022 | 35154112 | PubTator, text mining | PubMed |
| Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4. | Cell Chem Biol | 2022 | 35148834 | PubTator, text mining | PubMed |
| Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. | iScience | 2022 | 35141507 | PubTator, text mining | PubMed |
| CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression. | Cancer Sci | 2022 | 35133065 | PubTator, text mining | PubMed |
| In vitro reconstitution reveals cooperative mechanisms of adapter protein-mediated activation of phospholipase C-γ1 in T cells. | J Biol Chem | 2022 | 35124007 | PubTator, text mining | PubMed |
| CRISPR activation and interference screens decode stimulation responses in primary human T cells. | Science | 2022 | 35113687 | PubTator, text mining | PubMed |
| Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling. | Biomed J | 2022 | 35091087 | PubTator, text mining | PubMed |
| Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. | Sci Rep | 2022 | 35075200 | PubTator, text mining | PubMed |
| Systems-level conservation of the proximal TCR signaling network of mice and humans. | J Exp Med | 2022 | 35061003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=28